CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer

Hsieh, CC; Hsu, SH; Lin, CY; Liaw, HJ; Li, TW; Jiang, KY; Chiang, NJ; Chen, SH; Lin, BW; Chen, PC; Chan, RH; Lin, PC; Yeh, YM; Shen, CH

Shen, CH (通讯作者),Natl Hlth Res Inst, Natl Inst Canc Res, Tainan 704, Taiwan.;Shen, CH (通讯作者),Natl Chung Hsing Univ, Biotechnol Ctr, PhD Program Tissue Engn & Regenerat Med, Taichung 402, Taiwan.

BRITISH JOURNAL OF CANCER, 2022; 127 (9): 1615